cidofovir
cidofovir is a pharmaceutical drug with 26 clinical trials. Currently 2 active trials ongoing. Historical success rate of 94.4%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
9
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.0%
17 of 21 finished
19.0%
4 ended early
2
trials recruiting
26
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis
Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
Clinical Trials (26)
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis
Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis
Use of Cidofovir for Recurrent Respiratory Papillomatosis
Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.
Intravesical Cidofovir for Hemorrhagic Cystitis
A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.
Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus
Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
Cidofovir in Renal Transplant Recipients With BKVN
HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy
A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 26